News

Annie Lévesque cannot keep quiet any longer. She has joined voices with the 4, 000 Canadians who have called on the provincial and federal governments to find solutions to joint replacement delays affecting osteoarthritis patients. In March 2020, at the very beginning of the pandemic, Annie’s...

Arthritis Society president and CEO Trish Barbato talks with the Discovery Pod about joining the organization just before the COVID-19 pandemic, the challenges facing charities in the face of a global shutdown, and how innovation will play a key role as the organization evolves to meet the...

Dr. Arif Jetha from the Institute of Work and Health examines the impact of COVID-19 on workers with hidden health conditions. Our chief science officer, Dr. Sian Bevan, comments on the concerns expressed by people with arthritis. Dr. Jetha's work is partly funded by an Arthritis Society...

In this powerful perspective piece, Mari "Dev" Ramsawakh, who lives with a chronic pain and fatigue from a disability, writes about how COVID-19 has suddenly made accessibility everybody's priority. People with arthritis can identify.  

Chloroquine and hydroxychloroquine supplies are low due to coronavirus, causing concern for patients who rely on the drugs to treat conditions like lupus and rheumatoid arthritis. The Arthritis Society is working with governments to limit the extent to which arthritis patient care impacted by...

Our Chief Science Officer, Dr. Sian Bevan, and arthritis ambassador Darlene McPherson, comment on how COVID-19 has led to a shortage of Hydroxychloroquine – a drug used to treat Rheumatoid Arthritis and Lupus – and how it's impacting patients. The Arthritis Society continues to...

The COVID-19 (Novel coronavirus) pandemic has quickly infected over a million people worldwide.  While most people with COVID-19 infections have mild or no symptoms, a significant proportion of patients can become quite ill. At this time, little is known about how patients with rheumatic...

CTV coverage of The Conference Board of Canada Report on Canadian's access to arthritis medications. Features interviews with ambassador Darlene McPherson, who lives with RA, and Joanne Di Nardo, Arthritis Society Director of Public Policy & Government Affairs.

Physiology and pharmacology professor Frank Beier and chemistry professor Elizabeth Gillies have joined forces in a study developing a new treatment for arthritis sufferers. Beier and Gillies gained acknowledgement for their contributions by the Arthritis Society of Canada as one of the Top 10...